Michael Shalmi
Chairman at ACTIVE BIOTECH AB
Network origin in Michael Shalmi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.
26
| Operating Division | Investment Managers | 26 |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
17
| Subsidiary | Miscellaneous | 17 |
| Public Company | Biotechnology | 12 | |
Momentum Gruppen A/S
 Momentum Gruppen A/S Electric UtilitiesUtilities Momentum Gruppen A/S provides and administrates solar and wind projects. It specializes in procuring, disseminating, and managing solar and wind projects. The firm assists in planning, construction, operational, asset life extension, repowering, decommissioning, and sales and sourcing of projects. The company was founded by Kim Madsen in 2005 and is headquartered in Roskilde, Denmark.
4
| Private Company | Electric Utilities | 4 |
Env Holdcoco AS
 Env Holdcoco AS Financial ConglomeratesFinance Env Holdcoco AS is an investment holding Danish company.
1
| Private Company | Financial Conglomerates | 1 |
Sonion Holdco A/S
 Sonion Holdco A/S Financial ConglomeratesFinance Part of Sonion A/S, Sonion Holdco A/S is an investment holding Danish company. The private company is based in Hellerup, Denmark.
1
| Subsidiary | Financial Conglomerates | 1 |
Xellia Holdco A/S
1
| Private Company | 1 | |
Momentum Energy Karrebæk Holding K/S
 Momentum Energy Karrebæk Holding K/S Financial ConglomeratesFinance Momentum Energy Karrebæk Holding K/S is an investment holding private company based in Roskilde, Denmark. and has subsidiaries in Denmark. Momentum Energy Karrebæk Holding K/S functions as an investment holding Danish company. The company was founded in 2021 and the CEO is Kim Madsen.
1
| Private Company | Financial Conglomerates | 1 |
Momentum Energy Group A/S
 Momentum Energy Group A/S Electric UtilitiesUtilities Momentum Energy Group A/S is a holding Danish company that provides electricity production services. The private company is based in Roskilde, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi.
1
| Private Company | Electric Utilities | 1 |
Novo Invest 1 A/S
 Novo Invest 1 A/S Financial ConglomeratesFinance Novo Invest 1 A/S provides investment services. The private company is based in Hellerup, Denmark.
1
| Private Company | Financial Conglomerates | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Shalmi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Chairman Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member President | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member Corporate Officer/Principal Chairman | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chairman Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Doctorate Degree Doctorate Degree | |
DADES A/S
 DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Director/Board Member Director/Board Member Chairman | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aarhus | College/University | Graduate Degree Doctorate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Director/Board Member Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Chief Investment Officer Private Equity Investor Private Equity Investor Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal Director of Investments Director of Investments Private Equity Investor | |
| NNIT A/S | Information Technology Services | Director/Board Member Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The private company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Psoriasis+Creams Sweden AB | Chairman Director/Board Member | ||
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal Chief Investment Officer Director/Board Member | |
| Active Security Trading AB | Director/Board Member Chairman Director/Board Member | ||
| Actinova AB | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 24 |
| Denmark | 22 |
| United Kingdom | 5 |
| United States | 2 |
| Norway | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operational
| Director/Board Member | 518 |
| Chairman | 192 |
| Corporate Officer/Principal | 133 |
| Independent Dir/Board Member | 94 |
| Chief Executive Officer | 74 |
Most connected contacts
| Insiders | |
|---|---|
| Birgitta Monica Caneman | 59 |
| Eivind Kolding | 50 |
| Johan Rutger Christenson | 35 |
| Peter Sjöstrand | 35 |
| Maria Christina Schauman | 32 |
| Alf Gunnar Martin Nicklasson | 31 |
| Sten Scheibye | 31 |
| Nanna Liebach Lüneborg | 29 |
| Peter Bisgaard | 28 |
| Torbjørn Bjerke | 27 |
| Samir Kamal | 27 |
| Håkan Åström | 26 |
| Jeppe Fonager Christiansen | 26 |
| Peter Moldt | 25 |
| Karl Peter Thelin | 24 |
- Stock Market
- Insiders
- Michael Shalmi
- Company connections
